公司核心进展 - MindWalk Holdings Corp 宣布其通用流感项目取得进展 该进展基于发现了一个在流感病毒持续进化中仍保持不变的突破性功能约束 [1] - 公司利用其获得专利的HYFT® Deep Data技术 识别出一个嵌入流感生物学中且保持完整的功能模式 [1] 公司业务与技术 - MindWalk Holdings Corp 是一家生物原生人工智能治疗研究与技术公司 在纳斯达克上市 股票代码为HYFT [1] - 公司的技术平台HYFT® Deep Data用于识别生物学中的功能性模式 此次在流感病毒研究中得到应用 [1] 行业与研发领域 - 公司专注于流感病毒的通用治疗研究 该领域面临病毒持续进化的挑战 [1] - 此次进展涉及对跨流感病毒物种的持久功能性约束的识别 这属于生物医学和人工智能交叉的前沿研究领域 [1]

指数成分调整 - 沃尔玛公司将于2026年1月20日星期二市场开盘前 被纳入纳斯达克100指数 纳斯达克100等权重指数和纳斯达克100非科技板块指数 [1] - 此次调整中 阿斯利康公司将被从纳斯达克100指数 纳斯达克100等权重指数和纳斯达克100非科技板块指数中移除 [2] - 阿斯利康公司还将被从纳斯达克100 ESG指数 纳斯达克100除前30指数 纳斯达克100除前30 UCITS指数 纳斯达克100可持续ESG精选指数 纳斯达克100低波动率指数和纳斯达克100精选等权重指数中移除 [2] 指数概况 - 纳斯达克100指数是一个全球公认的指数 追踪在纳斯达克股票市场上市的100家最大的非金融公司 涵盖广泛的行业和领域 [3] - 这些公司涉及的行业包括科技 零售 医疗保健 电信 生物技术和媒体 共同塑造了21世纪的新经济 [3] 公司背景 - 纳斯达克全球指数自1971年以来一直是透明 市场驱动的指数解决方案的领导者 提供涵盖资产类别 行业和地区的全面指数系列 [4] - 纳斯达克是一家领先的全球科技公司 为上市公司 投资经理 银行 经纪商和交易所运营商提供服务 其产品包括数据 分析 软件 交易所能力和以客户为中心的服务 [5]

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On August 15, 2025, Scorpion Capital published a report that described Soleno’s only product, Vyka ...

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Skye securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns.Bret leads the investing group The Biotech Forum, ...

作为沈阳科技创新的核心承载区，沈阳浑南科技城集聚了众多高校院所、科技企业和科研机构，创新资 源丰富。"科创咖啡汇"秉持"政府引导、企业主导、院校协同、金融赋能"的理念，打破传统科创交流的 时空与身份壁垒，让轻松氛围成为思想碰撞的催化剂。 从一杯咖啡的温暖邂逅，到全链条的服务支撑，"科创咖啡汇"正是浑南科技城优化软性营商环境的生动 实践。未来，浑南科技城将持续丰富活动形式、提升服务效能，让"科创咖啡汇"成为区域科创活力 的"展示窗"与人才集聚的"强磁场"。 本报讯（沈阳日报、沈报全媒体记者傅淞岩 通讯员庄昕）一饮醇香盈雅室，缕缕焦韵润心田。1月9 日，浑南科技城"科创咖啡汇"再次在锦联新经济产业园举行，"检验检测咖创团"在这次活动中正式成 立。检验检测领域的企业家、科研专家和政府工作人员一同围坐畅谈，以一杯咖啡为纽带，用有温度的 交流场景、全链条的服务支撑，创意与智慧的迸发，勾勒出浑南区软性营商环境的鲜活模样。 "科创咖啡汇"采用"1+N"布局模式，在火炬中心东北中心设立1个全产业领域总厅，打造全域科创人才 社交枢纽，同时在沈阳国际软件园、锦联新经济产业园等产业集聚区布局多个特色子厅，精准覆盖新一 代信息技术、 ...

Revolution is developing drugs that target a molecular driver of cancers. ...

LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures ("Vida†), a next-generation life sciences venture firm, today congratulates Aktis Oncology (Nasdaq: AKTS), a clinical-stage biotechnology company advancing a pipeline of alpha-emitting radiopharmaceuticals for the treatment of solid tumors. Aktis raised $318 million in its initial public offering, reflecting strong investor interest, its recently announced anchor investment by Eli Lilly and Company (NYSE: LLY), and pipeline momentum as the co. ...

Key Takeaways Global healthcare rebounded late in 2025 as U.S. drug pricing uncertainty eased, driving strong ETF inflows.Policy clarity, aging populations, and AI innovation are key drivers for healthcare growth in 2026.VHT, XLV and IXJ offer diversified exposure to healthcare's recovery while reducing single-stock risk.2025 was a tumultuous year for the global healthcare sector. For much of the year, policy uncertainty, particularly around U.S. drug pricing and trade barriers, weighed heavily on valuation ...

Key Takeaways PacBio introduced CiFi to generate haplotype-resolved genome assemblies from limited sample material.CiFi integrates 3C with PACB's HiFi sequencing to reduce costs and simplify complex genome projects.PacBio expects CiFi to unlock new use cases and enhance HiFi systems without requiring new hardware.Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, announced a new community-developed method, CiFi, yesterday. It enables chromosome-scale, haplotype-resolved genome assem ...